MFDS — authorised 9 December 1983
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇰🇷 Gaviscon in South Korea
MFDS authorised Gaviscon on 9 December 1983
Marketing authorisation
Gaviscon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Gaviscon approved in South Korea?
Yes. MFDS authorised it on 9 December 1983.
Who is the marketing authorisation holder for Gaviscon in South Korea?
SANOFI AVENTIS US holds the South Korean marketing authorisation.